MagnaPharm Poland Sp. z o.o. secures contract for Medicinal Products for the Musculo-Skeletal System-Delivery of the drug used to treat patients with anhondroplasia (B166)

Posted On: 2025-08-12

Poland, Aug. 12 -- Poland based MagnaPharm Poland Sp. z o.o. has secured contract from Wojewodzki Szpital Dzieciecy im. J. Brudzinskiego w Bydgoszczy for Medicinal Products for the Musculo-Skeletal System-Delivery of the drug used to treat patients with anhondroplasia (B166). The value of the contract is worth 286640990 PLN.

Published by HT Digital Content Services with permission from Pivotal Sources....

To read the full article or to get the complete feed from this publication, please Contact Us.

Exclusive

Category

Source

Publication

Location

MagnaPharm Poland Sp. z o.o. secures contract for Medicinal Products for the Musculo-Skeletal System-Delivery of the drug used to treat patients with anhondroplasia (B166)